It appears that 2018 is the year CluePoints really established itself as a leader in the industry! Having recently being honoured in the Biotechnology Awards for our Industry leading Risk-Based Monitoring Software, in the form of the CluePoints Central Monitoring Platform, we’ve just been informed that we’ve clinched the title of “Most Reputable Clinical Trial RBM Software Solution 2018” in CV Magazine’s Corporate Excellence Awards 2018.
The CV Magazine Corporate Excellent Awards seek the “very best of the best” from across a vibrant and ever evolving business market to showcase the very best firms and the people driving them to success. The qualities recognised by the esteemed judging panel include:
- Its commitment to development & expansion
- Peer esteem & extent of clinical trials industry experience
- The physical & digital presence of the company
- Significant sponsor and CRO contracts,
- The global reach of the organization
- The previous accolades & achievements accrued by CluePoints
“It has been quite a year for CluePoints already. We conducted our first User Group Meeting in April and it was clear then that the momentum was building for our industry leading data quality software. Since then, we have signed several large Annual Enterprise License Agreements with Pharma and CRO clients and the rate of growth shows no sign of abating. We have a product roadmap that is unrivalled in the industry and all our clients are contributing to the ideas and innovation that will keep CluePoints as the clear market leader. This latest accolade is yet more evidence that our staff, customers and all stakeholders in the business are contributing to an analytics and data interrogation platform that is set to revolutionize the clinical trial management process and analytics space.” Patrick Hughes, Chief Commercial Officer.
CluePoints® is a Risk-Based Monitoring and Central Statistical Monitoring solution that has been designed and perfected over the last 15 years. It employs unique statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the ICH, FDA, and EMA, CluePoints® is deployed to support